PRMT5 and neoplasm: Deng et al. found that PRMT5 is an epigenetic activator of the AR in PCa cells, with knockdown of PRMT5 in AR + LNCaP suppressing the growth of xenograft tumours in mice, and inhibiting AR transcription [74].